PanGenetics, Tanox Biosystems deal

Tanox acquired a majority stock position in PanGenetics, a privately held developer of antibody-based drugs and vaccines with programs for autoimmune diseases, transplant rejection and allergy. PanGenetics will be renamed Tanox Pharma B.V. and will remain in Amsterdam. ...